Abstract
Background
Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory—Head and Neck Module (MDASI-HN).
Methods
Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics.
Results
From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3–15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population.
Conclusions
The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.
Similar content being viewed by others
References
Ingham J, Portenoy RK (2002) The measurement of pain and other symptoms. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, New York, pp 203–219
Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16–21
Kruse AL, Bredell M, Luebbers HT, Gratz KW (2010) Head and neck cancer in the elderly: a retrospective study over 10 Years (1999–2008). Head Neck Oncol 2:25
Wierzbicka M, Kuśnierkiewicz M, Wójtowicz JG, Maune S, Szyfter W (2001) The quality of life in head and neck cancer patients: description of randomized examination formula based on standardized questionnaires EORTC QLQ C-30, EORTC QTQ-H-N35 and Kiel questionnaire. Otolaryngol Pol 55:287–292
Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA (2004) Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:401–408
Torres-Carranza E, Infante-Cossío P, Hernández-Guisado JM, Hens-Aumente E, Gutierrez-Pérez JL (2008) Assessment of quality of life in oral cancer. Med Oral Patol Oral Cir Bucal 13(11):E735-41
Rogers SN, Ahad SA, Murphy AP (2007) A structured review and theme analysisof papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncol 43:843–868
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran DA, Bottomley A (2001) On behalf of the EORTC Quality o Life Group. EORTC QLQ-C30 Scoring Manual. Guidelines for assessing quality of life in EORTC Clinical Trials. 3 edn. EORTC, Brussels
Cleeland CS, Sloan JA (2010) Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. J Pain Symptom Manage 39(6):1077–1085
Guirimand F, Buyck JF, Lauwers-Allot E, Revnik J, Kerguen T, Aegerter P, Brasseur L, Cleeland CS (2010) Cancer-related symptom assessment in France: validation of the French M. D. Anderson symptom inventory. J Pain Symptom Manage 39(4):721–733
Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT 3rd, Unützer J, Vernon SW (2004) National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110–1117
Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008) Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26:2754–2760
Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B (2006) Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 10:83–89
Luoma ML, Hakamies-Blomqvist L, Sjöström J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmström P, Valvere V, Tennvall L, Blomqvist C (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39:1370–1376
Mehanna HM, Morton RP (2006) Patients’ views on the utility of quality of lifequestionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol 31:310–316
Meeuwsen EJ, German P, Melis RJ, Adang EM, Golüke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Schölzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG (2009) Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging 13:242–248
Kim MM, Califano JA (2004) Molecular pathology of head-and-neck cancer. Int J Cancer 112:545–553
Hilarius DL, Gundy CM, Aaronson NK (2008) Use of health-related quality-of-lifeassessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 113:628–637
Silveira AP, Gonçalves J, Sequeira T, Ribeiro C, Lopes C, Monteiro E, Pimentel FL (2010) Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol 2:32
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8(2):94–104
Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle M, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89(7):1634–1646
Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, Wang S, Cleeland CS (2007) Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head Neck 29(10):923–931
Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T (2004) Greek M.D. Anderson symptom inventory: validation and utility in cancer patients. Oncology 67(3-4):203–210
Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS (2005) Cancer-related symptom assessment in Russia: validation and utility of the Russian M.D. Anderson symptom inventory. J Pain Symptom Manage 30(5):443–453
Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS (2007) Taiwanese version of the M.D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage 33(2):180–188
Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y (2003) Japanese version of the M.D. Anderson symptom inventory: a validation study. J Pain Symptom Manage 26(6):1093–1104
Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS (2004) Chinese version of the M.D. Anderson symptom inventory: validation and application of symptom measurement in cancer patients. Cancer 101(8):1890–1901
Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS (2006) Filipino version of the M.D. Anderson symptom inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage 31:542–552
Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang S-M, Cleeland CS, Wang XS (2006) Validation study of the Korean version of the M.D. Anderson symptom inventory. J Pain Symptom Manage 31(4):345–352
Gunn GB, Koukourakis MI, Mendoza TR, Cleeland CS, Rosenthal DI (2012) Linguistic validation of the Greek M.D. Anderson symptom inventory – head and neck module. For Clin Oncol 3(1):29–31
Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P, Johnson C, Ramage J, Scott N, West K, EORTC Quality of Life Group (2007) Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 43(12):1810–1820
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcome 4:79
Mear I, Giroudet C (2012) Linguistic validation procedures. In: Acquadro C, Conway K, Giroudet C, Mear I (eds) Linguistic validation manual for health outcome assessments, 2nd edn. MAPI Institute, Lyon, pp 33–117
Willis GB (2005) Cognitive interviewing: a tool for improving questionnaire design. Sage, Thousand Oaks
Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM (2004) How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol 22(17):3485–3490
Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113(10):2704–2713
Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26(8):1355–1363
List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E (1996) The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 77(11):2294–2301
Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS (2009) Development and initial validation of the thyroid cancer module of the M. D. Anderson symptom inventory. Oncology 76:59–68
Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS (2011) Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson symptom inventory. Oncologist 16:217–227
Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS (2013) Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecoloncol 130(2):323–328
Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirken-doll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS (2010) Validation and application of a module of the M. D. Anderson symptom inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116(8):2053–2063
Henry M, Habib LA, Morrison M, Yang JW, Li XJ, Lin S, Zeitouni A, Payne R, Macdonald C, Mlynarek A, Kost K, Black M, Hier M (2013) Head and neck cancer patients want us to support them psychologically in the post treatment period: survey results. Palliat Support Care 24:1–13
van der Meulen IC, May AM, de Leeuw JR, Koole R, Oosterom M, Hordijk GJ, Ros WJ (2014) Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer 110(3):593–601
Hammerlid E, Persson LO, Sullivan M, Westin T (1999) Quality-of-life effects of psychosocial intervention in patients with head and neck cancer. Otolaryngol Head Neck Surg 120(4):507–516
Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessel AC, Lewin JS, Ang KK, Kies MS, Gring I, Wang XS, Cleeland CS (2008) The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys 72(5):1355–1361
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greco, A., Orlandi, E., Mirabile, A. et al. Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation. Support Care Cancer 23, 3465–3472 (2015). https://doi.org/10.1007/s00520-015-2701-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-015-2701-1